The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells
Open accessAbstract
The role of autophagy in cisplatin anticancer action was investigated using human U251 glioma, rat C6 glioma and mouse L929 fibrosarcoma cell lines. A dose‐ and time‐dependent induction of autophagy was observed in tumour cells following cisplatin treatment, as demonstrated by up‐regulation of autophagy‐inducing protein beclin‐1 and subsequent appearance of acridine orange‐stained acidic autophagic vesicles. The presence of autophagosomes in cisplatin‐treated cells was also confirmed by electron microscopy. Inhibition of autophagy with lysosomal inhibitors bafilomycin A1 and chloroquine, or a PI3 kinase inhibitor wortmannin, markedly augmented cisplatin‐triggered oxidative stress and caspase activation, leading to an increase in DNA fragmentation and apoptotic cell death. The mechanisms underlying the protective effect of autophagy apparently involved the interference with cisplatin‐induced modulation of Bcl‐2 family proteins, as inhibition of autophagy potentiated cisplatin‐mediated up‐regulation of proapoptotic Bax and down‐regulation of anti‐apoptotic Bcl‐2. Autophagy induction in cisplatin‐treated cells was preceded by activation of adenosine monophosphate‐activated protein kinase (AMPK) and concomitant down‐regulation of mammalian target of rapamycin (mTOR)‐mediated phosphorylation of p70S6 kinase. The ability of cisplatin to trigger autophagy was reduced by small interfering RNA (siRNA)‐mediated AMPK silencing, while transfection with mTOR siRNA was sufficient to trigger autophagy in tumour cells. Finally, siRNA‐mediated AMPK down‐regulation and AMPK inhibitor compound C increased cisplatin‐induced tumour cell death, while mTOR siRNA and AMPK activator metformin protected tumour cells from cisplatin. Taken together, these data suggest that cisplatin‐triggered activation of AMPK and subsequent suppression of mTOR activity can induce an autophagic response that protects tumour cells from cisplatin‐mediated apoptotic death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shibuya, H., Kato, Y., Saito, M., Isobe, T., Tsuboi, R., Koga, M., Toyota, H., & Mizuguchi, J. (2003) · Melanoma Research · doi:10.1097/00008390-200310000-00004 · Cited by 46
Cited by
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., & Shi, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0648-1 · Cited by 735
Dalby, K., Tekedereli, I., Lopez-Berestein, G., & Ozpolat, B. (2010) · Autophagy · doi:10.4161/auto.6.3.11625 · Cited by 446
Maycotte, P., & Thorburn, A. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14627 · Cited by 393
Metadata
- Authors
- Harhaji‐Trajkovic, L., Vilimanovich, U., Kravic‐Stevovic, T., Bumbasirevic, V., & Trajkovic, V.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 13
- Issue
- 9b
- Pages
- 3644-3654
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W1964275068
- Cited by
- 189
- References
- 1
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00663.x
- The paper
- Harhaji‐Trajkovic, L., Vilimanovich, U., Kravic‐Stevovic, T., Bumbasirevic, V., & Trajkovic, V. (2009). AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00663.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.